OCT 28·tradingview.comMed
BTMD Q3'26 Earnings: revenue estimate is 44.01M USD
BTMD (Biote Corp.) will release Q3'26 earnings on November 04. Analysts expect $44.01M revenue and -$0.01 EPS. Results will be announced after market close.
StockNASDAQ · US · USDHealthcare · Medical Care Facilities
$BTMD
biote Corp.
Price · $BTMDvia TradingView
AI sentiment · 7d1 articles
- Bullish
- 0
- Neutral
- 0
- Bearish
- 1
Insider · 30dAll trades →
No SEC Form 4 filings for $BTMD in the last 30 days.
See all $BTMD insider activity →Top stories · $BTMDMore →
AUG 28·stocktitan.net
biote Corp. (BTMD) gains new investor with 5.9% stake
Amit Agarwal, a U.S. private investor, disclosed a 5.92% stake in biote Corp. (BTMD), owning 1.7 million Class A shares with sole voting and dispositive power. The filing was made via a Schedule 13G on August 28, 2026.
AUG 12·SEC EDGAR
Beer Marc D purchased $202K of BTMD
Beer Marc D (Executive Chairman) purchased 131,950 shares of biote Corp. (BTMD) at an average of $1.53 ($1.53–$1.55, $0.20M total) across 2 trades over 2026-08-10 to 2026-08-11.
BTMD sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 1 news story mentioning BTMD (biote Corp.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent BTMD coverage spans financial news, earnings and insider activity.
What's driving BTMD
Weak earnings estimate may pressure the stock.
New sizable shareholder could influence future corporate actions or board composition.
Insider open-market buying is a modest bullish signal, but it is not a fundamental catalyst like earnings or guidance.
Q2 results and guidance reset the near-term profitability outlook, with margin pressure tied to third-party pellet sourcing and legal costs.
The recall-driven revenue and margin pressure plus guidance revision create a near-term earnings risk and a second-half recovery narrative.
AlphAI scores every news story that mentions BTMD with an AI model for sentiment and relevance, and aggregates insider trades from biote Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $BTMD
Score
BTMD Q3'26 Earnings: revenue estimate is 44.01M USD
BTMD (Biote Corp.) will release Q3'26 earnings on November 04. Analysts expect $44.01M revenue and -$0.01 EPS. Results will be announced after market close.
1 min readbiote Corp. (BTMD) gains new investor with 5.9% stake
Amit Agarwal, a U.S. private investor, disclosed a 5.92% stake in biote Corp. (BTMD), owning 1.7 million Class A shares with sole voting and dispositive power. The filing was made via a Schedule 13G on August 28, 2026.
1 min readBeer Marc D purchased $202K of BTMD
Beer Marc D (Executive Chairman) purchased 131,950 shares of biote Corp. (BTMD) at an average of $1.53 ($1.53–$1.55, $0.20M total) across 2 trades over 2026-08-10 to 2026-08-11.
2 min readbiote Q2 Earnings Call Highlights
Biote (NASDAQ: BTMD) reported Q2 net loss of $7.4M ($0.23/share) versus prior-year net income of $3.9M, and adjusted EBITDA of $5.6M (12.6% margin). Gross margin fell to 65.4% from 71.6% due to higher-cost third-party pellets during a disruption and $600k recall-related costs. Biote cut its 2026 outlook to revenue above $175M and adjusted EBITDA above $25M.
6 min readBiote Reports Second Quarter 2026 Financial Results
biote Corp. (BTMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Biote Reports Second Quarter 2026 Financial Results Continued progress in advancing strategic initiatives Updates full-year outlook Second Quarter 2026 Financial Highlights • Revenue of $44.2 million • Gross profit margin of 65.4% • Net loss of $(7.4) million and diluted loss per
6 min read
Biote Corp. (BTMD) Releases Q1 2026 Earnings: Revenue Falls 8.3% While EPS Beats Estimates
Biote Corp. (BTMD) reported its Q1 2026 earnings, with revenue declining 8.3% year-over-year to $44.9 million, falling short of analyst estimates. Despite the revenue miss, diluted EPS of $0.06 surpassed the estimated $0.05. The company also showed tighter liquidity and reduced capital spending, with cash and cash equivalents down 87.2% year-over-year.
3 min readBiote (BTMD) details 2026 virtual meeting, board elections and pay
Biote Corp. (BTMD) has announced its 2026 annual virtual stockholder meeting for May 12, 2026, where shareholders will vote on electing two Class I directors and ratifying Deloitte & Touche LLP as its independent auditor. The proxy statement also provided details on board composition, corporate governance, and executive and director compensation, including stock option awards and bonuses tied to the company's 2025 performance. Key financial figures and beneficial ownership information were also disclosed.
2 min readbiote (BTMD) Balance Sheet & Financial Health Metrics
This article provides an overview of biote (BTMD)'s financial health and balance sheet metrics. It highlights key figures such as a negative shareholder equity of $-50.4M and total debt of $107.0M, resulting in a debt-to-equity ratio of -212.4%. The company's EBIT is $35.1M, with an interest coverage ratio of 3.2, and it holds $24.1M in cash and short-term investments.
3 min read
biote (BTMD) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, November 5, 2025 at 5:00 p.m. ETChief Executive Officer - Bret ChristensenContinue reading ...
3 min read
biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates
biote Corp. (BTMD) delivered earnings and revenue surprises of +340.00% and +0.54%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
4 min read